Arida et al. found that the plasma concentration of PCSK9, as well as the ratio of PCSK9 to LDLR, demonstrated a positive correlation with the onset and progression of atherosclerosis in many RA patients. This evidence concerns the gene PCSK9 and atherosclerosis.